Which Path Is Right for You
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase
Phase 3 extends the testing to larger groups, longer durations, and more diverse patient populations
Healthcare providers increasingly recognize that obesity is a complex chronic disease influenced by genetics, hormones, metabolism, lifestyle, environment, and medical conditions
Dose optimization, medication switching (such as adding PlexusDx GLP-Squared for dual-compound benefit), or Precision Peptide Genetic testing can help identify whether a different approach might accelerate progress
Its triple agonist mechanism and superior weight loss data will need to justify what will likely be premium pricing